BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 29346535)

  • 1. Tricuspid regurgitation in acute heart failure: is there any incremental risk?
    Mutlak D; Lessick J; Khalil S; Yalonetsky S; Agmon Y; Aronson D
    Eur Heart J Cardiovasc Imaging; 2018 Sep; 19(9):993-1001. PubMed ID: 29346535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of Increased Cardiovascular Risk due to Functional Tricuspid Regurgitation in Patients with Left-Sided Heart Disease.
    Mutlak D; Khoury E; Lessick J; Kehat I; Agmon Y; Aronson D
    J Am Soc Echocardiogr; 2019 Dec; 32(12):1538-1546.e1. PubMed ID: 31624025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tricuspid regurgitation progression and regression in pulmonary arterial hypertension: implications for right ventricular and tricuspid valve apparatus geometry and patients outcome.
    Medvedofsky D; Aronson D; Gomberg-Maitland M; Thomeas V; Rich S; Spencer K; Mor-Avi V; Addetia K; Lang RM; Shiran A
    Eur Heart J Cardiovasc Imaging; 2017 Jan; 18(1):86-94. PubMed ID: 26873457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Tricuspid Regurgitation With Outcome in Acute Heart Failure.
    Cocianni D; Stolfo D; Perotto M; Contessi S; Barbisan D; Savonitto G; Rizzi JG; Barbati G; Merlo M; Altinier A; Sinagra G
    Circ Cardiovasc Imaging; 2023 Jul; 16(7):566-576. PubMed ID: 37381900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and impact of preoperative moderate/severe tricuspid regurgitation on patients undergoing transcatheter aortic valve replacement.
    Barbanti M; Binder RK; Dvir D; Tan J; Freeman M; Thompson CR; Cheung A; Wood DA; Leipsic J; Webb JG
    Catheter Cardiovasc Interv; 2015 Mar; 85(4):677-84. PubMed ID: 24740834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tricuspid Regurgitation Is Associated With Increased Risk of Mortality in Patients With Low-Flow Low-Gradient Aortic Stenosis and Reduced Ejection Fraction: Results of the Multicenter TOPAS Study (True or Pseudo-Severe Aortic Stenosis).
    Dahou A; Magne J; Clavel MA; Capoulade R; Bartko PE; Bergler-Klein J; Sénéchal M; Mundigler G; Burwash I; Ribeiro HB; O'Connor K; Mathieu P; Baumgartner H; Dumesnil JG; Rosenhek R; Larose E; Rodés-Cabau J; Pibarot P
    JACC Cardiovasc Interv; 2015 Apr; 8(4):588-96. PubMed ID: 25819185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Right ventricular function in heart failure with preserved ejection fraction: a community-based study.
    Mohammed SF; Hussain I; AbouEzzeddine OF; Takahama H; Kwon SH; Forfia P; Roger VL; Redfield MM
    Circulation; 2014 Dec; 130(25):2310-20. PubMed ID: 25391518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic relevance of mitral and tricuspid regurgitation in patients with severe aortic stenosis.
    Zilberszac R; Gleiss A; Binder T; Laufer G; Grimm M; Gabriel H; Maurer G; Rosenhek R
    Eur Heart J Cardiovasc Imaging; 2018 Sep; 19(9):985-992. PubMed ID: 29506023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, Determinants, and Prognostic Significance of Pulmonary Hypertension in Elderly Patients Admitted with Acute Decompensated Heart Failure: A Report from the BIO-HF Registry.
    Vanhercke D; Pardaens S; Weytjens C; Vande Kerckhove B; De Laet N; Janssens E; Van Camp G; De Sutter J
    Echocardiography; 2015 Sep; 32(9):1333-8. PubMed ID: 25470753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of concomitant tricuspid regurgitation on long-term outcomes in severe aortic stenosis.
    Amano M; Izumi C; Taniguchi T; Morimoto T; Miyake M; Nishimura S; Kitai T; Kato T; Kadota K; Ando K; Furukawa Y; Inada T; Inoko M; Ishii K; Sakaguchi G; Yamazaki F; Koyama T; Komiya T; Yamanaka K; Nishiwaki N; Kanemitsu N; Saga T; Ogawa T; Nakayama S; Tsuneyoshi H; Iwakura A; Shiraga K; Hanyu M; Ohno N; Fukumoto A; Yamada T; Nishizawa J; Esaki J; Minatoya K; Nakagawa Y; Kimura T
    Eur Heart J Cardiovasc Imaging; 2019 Mar; 20(3):353-360. PubMed ID: 30085068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcome of isolated tricuspid regurgitation.
    Topilsky Y; Nkomo VT; Vatury O; Michelena HI; Letourneau T; Suri RM; Pislaru S; Park S; Mahoney DW; Biner S; Enriquez-Sarano M
    JACC Cardiovasc Imaging; 2014 Dec; 7(12):1185-94. PubMed ID: 25440592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of pulmonary hypertension on long-term outcome in patients with severe aortic stenosis.
    Levy F; Bohbot Y; Sanhadji K; Rusinaru D; Ringle A; Delpierre Q; Smaali S; Gun M; Marechaux S; Tribouilloy C
    Eur Heart J Cardiovasc Imaging; 2018 May; 19(5):553-561. PubMed ID: 29106494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two simple echo-Doppler measurements can accurately identify pulmonary hypertension in the large majority of patients with chronic heart failure.
    Lanzarini L; Fontana A; Campana C; Klersy C
    J Heart Lung Transplant; 2005 Jun; 24(6):745-54. PubMed ID: 15949736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of functional tricuspid regurgitation on heart failure and death in patients with functional mitral regurgitation and left ventricular dysfunction.
    Agricola E; Stella S; Gullace M; Ingallina G; D'Amato R; Slavich M; Oppizzi M; Ancona MB; Margonato A
    Eur J Heart Fail; 2012 Aug; 14(8):902-8. PubMed ID: 22552182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional tricuspid regurgitation and recurrent admissions in patients with acute heart failure.
    De la Espriella R; Santas E; Chorro FJ; Miñana G; Soler M; Bodí V; Valero E; Núñez E; Bayés-Genis A; Lupón J; Sanchis J; Núñez J
    Int J Cardiol; 2019 Sep; 291():83-88. PubMed ID: 30955879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction.
    Koelling TM; Aaronson KD; Cody RJ; Bach DS; Armstrong WF
    Am Heart J; 2002 Sep; 144(3):524-9. PubMed ID: 12228791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and prognosis of patients with significant tricuspid regurgitation.
    Bohbot Y; Chadha G; Delabre J; Landemaine T; Beyls C; Tribouilloy C
    Arch Cardiovasc Dis; 2019 Oct; 112(10):604-614. PubMed ID: 31558358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and echocardiographic correlates of pulmonary hypertension among heart failure patients in Lagos, south-western Nigeria.
    Kushimo OA; Mbakwem AC; Ajuluchukwu JN; Amadi CE
    Cardiovasc J Afr; 2019 Jan/Feb 23; 30(1):9-14. PubMed ID: 30398285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Tricuspid Regurgitation on Clinical Outcomes: The COAPT Trial.
    Hahn RT; Asch F; Weissman NJ; Grayburn P; Kar S; Lim S; Ben-Yehuda O; Shahim B; Chen S; Liu M; Redfors B; Medvedofsky D; Puri R; Kapadia S; Sannino A; Lindenfeld J; Abraham WT; Mack MJ; Stone GW
    J Am Coll Cardiol; 2020 Sep; 76(11):1305-1314. PubMed ID: 32912445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Outcome of Isolated Tricuspid Regurgitation in Patients with Preserved Left Ventricular Ejection Fraction and Pulmonary Hypertension.
    Bar N; Schwartz LA; Biner S; Aviram G; Ingbir M; Nachmany I; Margolis G; Sadeh B; Barashi R; Keren G; Topilsky Y
    J Am Soc Echocardiogr; 2018 Jan; 31(1):34-41. PubMed ID: 29191730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.